Quantcast
Last updated on April 16, 2014 at 13:48 EDT

Latest Implications of US gene patent invalidation on Australia Stories

2013-08-15 08:29:35

-- Will continue to offer fast, accurate, and affordable alternative for BRCA1/2 testing -- HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics. Both companies are also countersuing Myriad for violations of the Federal Antitrust Act. On June 13, 2013,...

2013-06-18 23:03:27

The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry reliance on the Patent Office´s grant of more than 3,000 patents over 30 years to a footnote for Congressional action. (PRWEB) June 18, 2013 The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry...

2013-06-13 16:26:23

WASHINGTON, June 13, 2013 /PRNewswire-USNewswire/ -- In a unanimous decision the U.S. Supreme Court has ruled that a person's genes, as they naturally exist in a person's body, are not patentable. The case involved a company, Myriad Genetics, that had patented two DNA sequences related to breast cancer risk, and had exclusive license on the diagnostic tests. (Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO) Of the decision Family Research Council (FRC) Senior Fellow Dr. David...

Biotech Firm Loses Supreme Court Fight To Patent Human Genes
2013-06-13 12:24:31

Lawrence LeBlond for redOrbit.com - Your Universe Online A Salt Lake City, Utah-based genetics firm has lost a battle in court to keep a patent on naturally-occurring human genes. The US Supreme Court has shot down Myriad Genetics Inc.´s bid to patent breast and ovarian cancer genes, ruling that human genes cannot be patented. The decision has immediate benefits for some cancer patients but may have long-lasting repercussions for biotechnology research. The decision, written up...

2013-04-15 00:20:43

TUCSON, Ariz., April 14, 2013 /PRNewswire-USNewswire/ -- The United States Supreme Court hears oral argument this Monday morning concerning the patentability of human genes, and the Association of American Physicians and Surgeons (AAPS) has urged the Court not to destroy incentives for private research. That would be the result if the Supreme Court issues a sweeping ruling in Ass'n for Molecular Pathology v. Myriad Genetics, Inc., Sup. Ct. No. 12-398, declaring categories of medical...

2013-03-14 12:28:40

TUCSON, Ariz., March 14, 2013 /PRNewswire-USNewswire/ -- Today the Association of American Physicians and Surgeons (AAPS) files an amicus brief with the U.S. Supreme Court in defense of patents for genetic and other medical research, including isolated BRCA genes, which are important risk factors in breast and ovarian cancer. The incentives created by such patents are essential to encourage medical innovation that saves patients' lives, and AAPS urges the Supreme Court not to exclude research...